The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.
暂无分享,去创建一个
J. Gohagan | Claire S Zhu | A. Black | Asia Khan | D. Carrick | Wen-Yi Huang | Kelly J. Yu | C. Williams | S. Yurgalevitch | Karen Pettit
[1] Stacey A. Kenfield,et al. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom‐related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial , 2016, BJU International.
[2] P. Hartge,et al. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. , 2014, Gynecologic oncology.
[3] N. Rothman,et al. Pooled Analysis of Mitochondrial DNA Copy Number and Lung Cancer Risk in Three Prospective Studies , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[4] Peter Kraft,et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer , 2014, Nature Genetics.
[5] Paolo Vineis,et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.
[6] E. Gillanders,et al. The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio. , 2014, Biopreservation and biobanking.
[7] N. Rothman,et al. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. , 2014, Cancer research.
[8] John D Potter,et al. Estimating the heritability of colorectal cancer. , 2014, Human molecular genetics.
[9] Joshua N Sampson,et al. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. , 2014, The American journal of clinical nutrition.
[10] S. Chanock,et al. Genome-wide association study of circulating vitamin D-binding protein. , 2014, The American journal of clinical nutrition.
[11] Julie Goodman,et al. Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer , 2014, International journal of cancer.
[12] D. Silverman,et al. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants , 2014, Epigenetics.
[13] R. Pfeiffer,et al. Circulating inflammation markers and prospective risk for lung cancer. , 2013, Journal of the National Cancer Institute.
[14] J. Gohagan,et al. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. , 2013, Journal of the National Cancer Institute.
[15] C. Friedenreich,et al. Genome-wide association study of endometrial cancer in E2C2 , 2013, Human Genetics.
[16] N. Rothman,et al. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. , 2013, Blood.
[17] Paolo Vineis,et al. Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.
[18] S. Chanock,et al. Genome-Wide Association Study of Serum Selenium Concentrations , 2013, Nutrients.
[19] Christian Gieger,et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture , 2013, Nature Genetics.
[20] Jane E. Carpenter,et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. , 2012, Human molecular genetics.
[21] Jianxin Shi,et al. Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk , 2012, Cancer.
[22] R. Hayes,et al. Prospective Study of Genomic Hypomethylation of Leukocyte DNA and Colorectal Cancer Risk , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[23] A. Baccarelli,et al. A Case-Control Study of Peripheral Blood Mitochondrial DNA Copy Number and Risk of Renal Cell Carcinoma , 2012, PloS one.
[24] Melissa Bondy,et al. Genome-wide association study of glioma and meta-analysis , 2012, Human Genetics.
[25] C. Carlson,et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk , 2011, Human Genetics.
[26] Peter Kraft,et al. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk , 2011, Genetic epidemiology.
[27] Peter Kraft,et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. , 2011, Journal of the National Cancer Institute.
[28] S. Chanock,et al. Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2011, PloS one.
[29] R. Sinha,et al. Iron Homeostasis and Distal Colorectal Adenoma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2011, Cancer Prevention Research.
[30] J. Witte,et al. Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer. , 2011, Omics : a journal of integrative biology.
[31] D. Chasman,et al. Genome-Wide Association Study of Relative Telomere Length , 2011, PloS one.
[32] E. Rimm,et al. Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption , 2011, PLoS genetics.
[33] Sudhir Srivastava,et al. A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer , 2011, Cancer Prevention Research.
[34] R. Sinha,et al. A Prospective Evaluation of C-reactive Protein Levels and Colorectal Adenoma Development , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[35] I. M. Jones,et al. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2010, Carcinogenesis.
[36] Paolo Vineis,et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 , 2011, Nature Genetics.
[37] M. Thun,et al. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. , 2010, Human molecular genetics.
[38] William Wheeler,et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.
[39] M. Haznadar,et al. Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk. , 2010, International journal of molecular epidemiology and genetics.
[40] C. McCarty,et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[41] William Wheeler,et al. Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.
[42] Tanya M. Teslovich,et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .
[43] Neil E Caporaso,et al. B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.
[44] Ying Wang,et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. , 2009, American journal of human genetics.
[45] Heather A. Halvensleben,et al. A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33 , 2009, Human Genetics.
[46] Geoffrey S. Tobias,et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.
[47] R. Hayes,et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer , 2009, Aging cell.
[48] R. Sinha,et al. Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. , 2009, Cancer research.
[49] William Wheeler,et al. Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors , 2009, PloS one.
[50] R. Hayes,et al. Sexually Transmissible Infections and Prostate Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[51] Karin M. Fredrikson,et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers , 2008, Human Genetics.
[52] Nilanjan Chatterjee,et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. , 2008, Journal of the National Cancer Institute.
[53] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[54] R. Hayes,et al. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. , 2007, Cancer research.
[55] R. Hayes,et al. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. , 2006, Cancer research.
[56] Nilanjan Chatterjee,et al. Nucleotide Excision Repair Gene Polymorphisms and Risk of Advanced Colorectal Adenoma: XPC Polymorphisms Modify Smoking-Related Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.
[57] Robert N Hoover,et al. Methods for etiologic and early marker investigations in the PLCO trial. , 2005, Mutation research.
[58] R. Hayes,et al. GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[59] R. Hayes,et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[60] R. Hayes,et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[61] R. Hayes,et al. Whole blood cryopreservation in epidemiological studies. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[62] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[63] J. Gohagan,et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.